Giantcode About Us: Giantcode Plc, with its principle website www.giantcodecorp.com is a subsidiary of Giantcode Corp, Singapore. United Kingdom is the home to its registered office. Giantcode Corp primarily focuses on the development of a series of clinical objects that would provide resistance against kidney cancer, prostate cancer, liver cancer, pancreatic cancer, gastro-intestinal cancers and lung cancer. Such types of cancers are life threatening as the treatments and medicines of today are not apt for its treatment. Giantcode Corp primary aim is to improve the health condition of the cancer patients through the innovation of treatments that would cure cancer diseases.